Please regularly visit the following websites and directly search for funding opportunities and deadlines in your research field.
New Opportunities
- NIH Highlighted Topic: Training and Career Development in Dissemination and Implementation (D&I) Science: The purpose of this highlighted topic is to encourage research training in D&I science, including Fellowships, Career Development Awards, Institutional Research Training Grants, and Education Projects. D&I research training areas of interest include but are not limited to D&I theories, models and frameworks; D&I strategies; D&I outcomes and outcome measures; community engaged research approaches; qualitative and mixed methods; human centered design or design thinking method; analytic methods for D&I research; pragmatic clinical trials; planning, tracking and measuring adaptations to innovations or implementation strategies; and theories and methods to understand and reduce health disparities. More information, including program officer contacts, is available on the highlighted topic webpage. This topic expires on April 14, 2027
- NIH Highlighted Topic: Implementation Science to Optimize HIV Prevention and Treatment: This topic encourages implementation research to advance innovative strategies to deliver biomedical prevention and treatment options toward ending the HIV epidemic. Applications may include strategies to optimize the delivery, uptake and adoption of novel long-acting therapeutic options, behavioral interventions to achieve viral suppression, strategies to address comorbidities in people with HIV, and practices that integrate and sustain evidence-based HIV prevention and care in a variety of settings. More information, including program officer contacts, is available on the highlighted topic webpage. This topic expires on December 2, 2026.
- NIH Highlighted Topic: Advancing Nanotechnology Research to Improve Diagnosis and Treatment Options: This topic encourages the use of nanotechnology approaches, with a particular focus on extracellular vesicles (EVs) that are associated with homeostasis, development, regeneration, and pathogenesis in all areas of disease. Nanotechnology tools for early disease detection, therapeutics and drug delivery are of interest. This topic encourages studies that incorporate new approach methodologies (NAMs) and novel technologies (e.g., system-omics methods, high-throughput assays, digital Flow Cytometry, artificial intelligence (AI), other computational approaches) to study EVs in disease and the use of EVs in detection and treatment. More information, including program officer contacts, is available on the highlighted topic webpage. This topic expires on March 10, 2027.
- NIH Highlighted Topic: Drug Discovery for Nervous System Disorders: The overarching purpose of this topic is to accelerate the process of drug discovery for nervous system disorders. Research projects may include activities to identify, optimize, and validate potential therapeutic candidates and may propose studies focused on all stages of the early drug discovery pipeline, from screening to candidate selection. Examples include, but aren't limited to, high, medium or low-throughput assays, medicinal chemistry to improve activity and selectivity, application of machine learning at any stage of drug discovery and initial DMPK and toxicity studies of candidate therapeutics. More information, including program officer contacts, is available on the highlighted topic webpage. This topic expires on January 28, 2027.
Federal Agencies
Explore NIH Funding: A search tool to filter funding opportunities on Grants.gov by NIH/HHS-specific categories like funding category, funding organization (e.g., NCI, NCATS) and keyword. NIH funding opportunities are now exclusively posted to Grants.gov.
NIH Highlighted Topics: A resource to help researchers identify research priority areas for NIH Institutes, Centers, and Offices. Investigators interested in a topic should apply through an appropriate funding opportunity, such as the NIH R01 Parent Funding Announcement (clinical trial not allowed) or other broad NIH opportunities on Grants.gov. Highlighted topics may or may not have dedicated funding.
Notices of Funding Opportunity of particular interest for pharmacy include:
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional): "The purpose of this Notice of Funding Opportunity (NOFO) is to support studies that will identify, develop, and/or test strategies for overcoming barriers to the adoption, adaptation, integration, sustainability, scale-up, and spread of evidence-based interventions, practices, programs, tools, treatments, guidelines, and policies (hereafter referred to as evidence-based interventions). Studies that promote equitable dissemination and implementation of evidence-based interventions among underrepresented communities are encouraged. Conversely, there is a benefit in understanding circumstances that create a need to stop or reduce (de-implement) the use of practices that are ineffective, unproven, low-value, or harmful. In addition, studies to advance dissemination and implementation research methods and measures are encouraged. Applications that focus on re-implementation of evidence-based health services that may be disrupted amidst disasters (e.g., pandemics, climate change) remain relevant." Upcoming application due dates: June 5, 2026
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional): Upcoming application due dates: June 16, 2026
- Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed): Upcoming application due dates: June 16, 2026
- The Medical Scientist Training Program (MSTP) T32: "The goal of the Medical Scientist Training Program (MSTP) is to develop a diverse pool of well-trained clinician-scientist leaders available to address the nation’s biomedical research needs. Specifically, this funding announcement provides support to eligible, domestic organizations to develop and implement effective, evidence-informed approaches to dual-degree training and mentoring that will keep pace with the rapid evolution of the biomedical research enterprise and lead to the completion of both a clinical degree (for example, M.D., D.O., D.V.M., D.D.S., Pharm.D., etc.) and a research doctorate degree (Ph.D.)."
- NIH Loan Repayment Programs: The NIH Loan Repayment Programs (LRP) were established by Congress to recruit and retain health professionals in biomedical and behavioral research careers. The LRPs repay up to $50,000 annually of a researchers qualified educational debt "in return for a commitment to engage in NIH mission-relevant research." Research areas include clinical research, pediatric research, health disparities research, contraception and infertility research, clinical research for individuals from disadvantaged backgrounds, and research in emerging areas critical to human health. More information is available on the LRP application page. The LRP application period closed on December 4, 2025. Updated due date information will be posted when available.
NSF Funding: The Foundation supports basic research and education in most fields, including biological, chemical, environmental, social, behavioral and economical sciences, collaborative research between universities and industry, and graduate and postdoctoral fellowships.
CDC Funding: Supports research to keep Americans safe and healthy both domestically and abroad.
USDA NIFA Grants: Supports research and fellowships on nutrition and health, education, environment, biotechnology and genomics, economics and community development.
AHRQ Funding & Grants: Supports research to improve the quality, safety, efficiency, and effectiveness of healthcare for all Americans. AHRQ currently does not have any open funding opportunities.
DOD Grants: The Department of Defense (DOD) Office of Congressionally Directed Medical Research Programs (CDMRP) supports biomedical research across the development pipeline from basic to clinical through annual funding opportunities.
Additional Organizations, Associations and Foundations
Proposal Central Provides access to funding opportunities funders including the Alzheimer’s Association, American Association for Cancer Research, Burroughs Wellcome Fund, and many others
American Brain Tumor Association
American Respiratory Care Foundation
International Rett Syndrome Foundation
National Pharmaceutical Council
Patient-Centered Outcomes Research Institute